Publication
Road to COP29: Our insights
The 28th Conference of the Parties on Climate Change (COP28) took place on November 30 - December 12 in Dubai.
Allocating Risks in Public-Private Partnership Contracts, 2016 edition
Global | Publication | July 2016
Working in partnership with the Global Infrastructure Hub (GI Hub), we have produced a tool for governments and infrastructure providers to assist in building a global pipeline of viable public private partnership (PPP) projects.
Hosted via an interactive online portal, the tool explores options for the allocation of risk between the public and private sectors in typical PPP transactions, along with related information on practical measures to help mitigate issues that arise and typical government support arrangements.
The report focuses on 12 types of projects within the following sectors:
- Transport: toll roads, ports, airports and rail
- Energy: solar PV, hydro power, power transmission and natural gas distribution
- Water and Sanitation: water desalination, water distribution and solid waste collection, disposal, landfill and recycling.
The report was welcomed by the Finance Ministers and Central Bank Governors of the G20 group of nations in Chengdu, China on 23-24 July.
The GI Hub, based in Sydney, Australia, is an organisation established by the G20 group of nations to foster innovation in global infrastructure development.
Recent publications
Publication
Country risk in unprecedented times: A precedent for cross-border loan documentation?
While country risk cannot be avoided in cross-border transactions entirely, it can be effectively mitigated through careful transaction structuring and tailored contractual protections.
Publication
The GCR Guide to Life Sciences – Merger control: Procedural issues
Miranda Cole, Julien Haverals and Emma Clarke of our Brussels/ London offices are the authors of a chapter on procedural issues in merger control that has been published in the third edition of the Global Competition Review’s The Guide to Life Sciences. This covers a number of significant procedural developments that have affected merger review of life sciences transactions.
Subscribe and stay up to date with the latest legal news, information and events . . .